ISRCTN41687085已完成未知
A randomised, open label controlled trial of Epoetin Beta in the treatment of Anaemia Post-Transplantation
Barts and the London NHS Trust (UK)0 个研究点目标入组 120 人开始时间: 2006年10月3日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Male and female patients greater than three months post-kidney transplant
- •2. Haemoglobin less than 11.5 g/dl and greater than 9.0 g/dl
- •3. Age greater than 18 years of age and less than 85 years of age
排除标准
- •1. Current treatment with an erythropoiesis stimulating agent (ESA)
- •2. Uncontrolled hypertension
- •3. Congestive cardiac failure (New York Heart Association [NYHA] grade III and IV)
- •4. History of seizures
- •5. History of thombotic episodes
- •6. Pregnancy
- •7. Lactation
- •8. Presence of systemic disease, infection or inflammatory conditions
- •9. Hepatic insufficiency
- •10. Active hepatitis
- •11. Uncontrolled hypothyroidism
- •12. Chronic alcoholism
- •13. Known hypersensitivity to the active substance in the cartridge or benzoic acid
- •14. Known sensitivity to Epoetin Beta
研究者
相似试验
进行中(未招募)
3 期
A Randomised Controlled Trial of the efficacy and safety of an Inhaled Corticosteroid and Long Acting Beta Agonist reliever therapy regimen in children with mild asthmaRespiratory - AsthmaAsthmaACTRN12620001091998Medical Research Institute of New Zealand360
已完成
不适用
A study comparing the efficacy of clindamycin plus quinine with coartem for treating Kenyan children with uncomplicated falciparum malariaMalariaPACTR201209000419241Kenya Medical Research Institute384
已完成
不适用
Open-labelled randomized controlled trial of the effect of PDA-based self-care system for type 2 diabetes versus usual care.type II DMJPRN-UMIN000002992Stress Science and Psychosomatic Medicine, Graduate School of Medicine, The University of Tokyo30
招募中
2 期
Open label, comparative, randomized trial of the efficacy, safety and bioavailability of highly concentrated inhalative epinephrine (4 mg L-Epinephrin/ml, Infectokrupp® Inhal) versus Epinephrin-Autoinjektor-Anwendung (Fastjekt® Junior) in infants with acute anaphylactic reaction in the course of a food challengeT78.0Anaphylactic shock due to adverse food reactionDRKS00011881Charité Campus Virchow-Klinikum40
已完成
不适用
An open-label randomized controlled trial on the efficacy of switching from insulin glargine U100 to insulin glargine U300 or insulin degludec in type2 diabetes mellitustype 2 diabetes mellitusJPRN-UMIN000025122Kanagawa-ken Keiyu-kai Keiyu hospital20
